The company, which designs its behavioral biometrics algorithms to fight fraud, has reported that it increased new sales in the quarter ended March 31 by 130 percent compared to the first quarter of 2022.
Read more here.
![[Zebra in The Jerusalem Post] Zebra wins FDA clearance for AI-based pleural effusion diagnosis tech](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Zebra in The Jerusalem Post] Zebra wins FDA clearance for AI-based pleural effusion diagnosis tech
December 2, 2019
[Remilk in Vegconomist] “Israel will be a major power in alternative protein” says Office of the Prime Minister
March 31, 2023
